Bills Biotech

Bills Biotech is a research-driven biopharmaceutical company based in Vadodara, India, specializing in the production of fermentation-based Active Pharmaceutical Ingredients (APIs). Founded in 2006, the company operates a state-of-the-art, WHO-GMP certified facility located in a dedicated Biotech Park. Its core expertise lies in fermentation, semi-synthetic, and synthetic processes, with a product portfolio focused on immunosuppressants, topical antibiotics, and anti-obesity treatments. Key commercial products include Tacrolimus and Mupirocin APIs and their respective topical formulations. Beyond its proprietary product line, Bills Biotech serves as a CDMO partner, offering contract research and manufacturing services for the biopharmaceutical, cosmeceutical, and nutraceutical industries. The company is committed to innovation through its dedicated R&D division, which focuses on strain improvement and process optimization.